Tel Aviv, Israel: A type of heart failure severely affects a patient's routine and requires frequent hospitalization, but now a heart transplant can ease the problem.
It has been developed by the Israeli company 'Restore Medical' which has been named as 'Contra Band'. In congestive heart failure, or CHF, the heart becomes so weak that the ability to push or pump blood is reduced. People with this condition barely survive 5 to 10 years. Blood does not flow out of the ventricle or valve and blood and fluid from the heart continue to reach the lungs.
CHF does not allow adequate blood to reach the whole body and makes it difficult to breathe. After a few steps, the patient becomes tired and gasps. It is important to know that CHF does not kill the heart but rather reduces its ability to shed blood. It usually involves an inverted valve or ventricle.
Now this condition can be removed to a great extent by inserting a wire-like device in the heart. It is inserted into the pulmonary artery. It notices the pressure of a healthy upright valve and increases its pressure, thereby correcting the inversion of the inverted valve.
It is delivered to the heart through a cord just like angioplasty. After an hour's procedure, the patient can go home the next day.
In this way the patient's condition improves. There is a benefit along with the medicine and the patient avoids going to the hospital again and again. First it was tested on animals, in the second phase it was tested on three humans.
It will be available worldwide by 2026, but FDA approval is in place. The company says it will test more humans in the meantime.
Contra band can be inactivated inside the heart and nothing happens to the patient instead of having to remove it again after any complication occurs after installation.
